NVO - Eli Lilly's oral weight-loss drug is potential winner analyst says
2024-06-18 13:30:13 ET
Eli Lilly’s ( NYSE: LLY ) success with a newer class of diabetes and weight-loss drugs has the potential to be repeated with other products in its research pipeline, healthcare analysts said Tuesday at the Seeking Alpha Investing Summit in New York....
Eli Lilly’s oral weight-loss drug is potential winner, analyst says